Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aptevo Therapeutics ( (APVO) ) has shared an update.
On July 24, 2025, Aptevo Therapeutics’ stockholders approved a range of potential reverse stock split ratios, after which the board on December 17, 2025 selected a 1-for-18 ratio and filed an amendment to the company’s certificate of incorporation, effective at 5:01 p.m. Eastern Time on December 29, 2025, to implement the reverse split. At the effective time, every 18 shares of issued and outstanding common stock was combined into one share with the same par value, with proportional adjustments made to equity awards and warrants, fractional stock positions settled in cash (or rounded up in the case of warrant exercises), and the overall percentage ownership of stockholders largely unchanged; the stock will begin trading on a split-adjusted basis on Nasdaq on December 30, 2025 under a new CUSIP, a move that can support compliance with listing standards and potentially improve the stock’s marketability.
The most recent analyst rating on (APVO) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Aptevo Therapeutics stock, see the APVO Stock Forecast page.
Spark’s Take on APVO Stock
According to Spark, TipRanks’ AI Analyst, APVO is a Underperform.
Aptevo Therapeutics’ stock score is significantly impacted by its challenging financial performance, marked by declining revenues, high leverage, and negative cash flows. The technical analysis indicates bearish momentum, while the valuation is weakened by persistent losses. However, promising developments in its oncology pipeline offer potential upside if successfully executed.
To see Spark’s full report on APVO stock, click here.
More about Aptevo Therapeutics
Aptevo Therapeutics Inc. is a Delaware-incorporated biopharmaceutical company whose common stock is listed on The Nasdaq Capital Market, giving it access to public equity markets and a broad base of retail and institutional investors.
Average Trading Volume: 2,300,082
Technical Sentiment Signal: Strong Sell
Current Market Cap: $10.23M
For detailed information about APVO stock, go to TipRanks’ Stock Analysis page.